Chronic spontaneous urticaria treated with omalizumab (Xolair): A proposal of standardized tapering protocol before withdrawal to achieve the minimal effective dosage-MedSci.cn

Chronic spontaneous urticaria treated with omalizumab (Xolair): A proposal of standardized tapering protocol before withdrawal to achieve the minimal effective dosage

Vano-Galvan, S; Hermosa-Gelbard, A; Saceda-Corralo, D; Pindado-Ortega, C; Rodrigues-Barata, R; Jaen-Olasolo, P

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018; 79 (3): AB73

科室
- - 订阅+
  - 更多科室
工具
服务